/Assets_headers/past_grants.jpg

Research Funding & GrantsYoung Investigator AwardsResearch Grants
Peter A. Kaufman, MD/Dartmouth-Hitchcock, Norris Cotton Cancer Center
Research conducted through the Molecular Therapeutics Research Program.
$3,500 awarded in 2004 to support Dr. Kaufman
$5,000 granted in 2005 for continued support of Dr. Kaufman
$6,100 granted in 2006 for continued support of Dr. Kaufman
$7,125 granted in 2007 for continued support of Dr. Kaufman
$7,000 granted in 2008 for continued support of Dr. Kaufman
$10,000 granted in 2009 for continued support of Dr. Kaufman

Mountain States Tumor Institute
2001: Clinical research related to monoclonal antibodies, a promising development in the treatment of breast cancer.
$6000

Dana Farber Cancer Institute - Donald Kufe, MD
2000: Trial using MUC1 gene in a phase I/II test to measure the safety of this vaccine in 18 women with metastatic breast cancer.
$7,500
$10,000 granted in 2001 for the same study

Michael F. Press, MD, Ph.D./USC / Kenneth Norris Comprehensive Cancer Center
Investigating mechanisms for Tumorigenesis in HER-2/neu overexpressing breast cancers.
$50,000 ($25,000 matched by USC / Kenneth Norris Comprehensive Cancer Center in 1999)
$50,000 ($25,000 matched by USC/ Kenneth Norris Comprehensive Cancer Center in 2000)
$26,000 granted in 2001 for continued support of Dr. Press
$33,000 granted in 2002 for continued support of Dr. Press
$82,000 granted in 2003 for continued support of Dr. Press
$23,800 granted in 2004 for continued support of Dr. Press
$28,000 granted in 2005 for continued support of Dr. Press
$23,100 granted for 2006 for continued support of Dr. Press
$27,000 granted in 2007 for continued support of Dr. Press
$5,500 granted in 2008 for continued support of Dr. Press
$5,500 granted in 2009 for continued support of Dr. Press

Todd Waldman, MD, Ph.D./ The Lombardi Cancer Center
1999: Used in the study of somatic cell gene targeting and human tumor suppressor genes to further development of novel anticancer agents.
$10,000

Mountain States Tumor Institute
Grant used to support data management of current breast cancer research protocols including bone marrow transplant procedures and the new Southwest Oncology adjuvant protocols.
$4,000 granted in 1999
$2,750 granted in 2000 to support further study
$3,300 granted in 2001 to support further study

Helena Chang, MD, Revlon UCLA Breast Center
Studies by of biological interventions in breast cancer prevention, diagnosis and treatment.
$50,000 ($25,000 matched by Jonsson Comprehensive Cancer Center in 1999)
$50,000 ($25,000 matched by Jonsson Comprehensive Cancer Center in 2000)
$26,000 granted in 2001 for continued support of Dr. Chang
$33,000 granted in 2002 for continued support of Dr. Chang
$18,000 granted in 2003 for continued support of Dr. Chang
$23,800 granted in 2004 for continued support of Dr. Chang
$28,000 granted in 2005 for continued support of Dr. Chang
$23,100 granted in 2006 for continued support of Dr. Chang

Anna Maria Lopez, MD, Arizona Cancer Center
1999: Grant to study the effect of Neuromuscular Integrative Action of (NIA) on the emotional and physical recovery of women with a history of breast cancer.
$20,000

Julie R. Gralow, MD, University Of Washington School Of Medicine
Grant used to study the changes in breast tissue that occur in response to the addition of phytoestrogens to the diet of post-menopausal women to determine if plant estrogens can be a safe and effective alternative to estrogen replacement therapy.
$5,000 granted in 1999
$18,500 granted in 2000 for continued support of Dr. Gralow
$12,000 granted in 2001 for continued support of Dr. Gralow
$10,000 granted in 2002 for continued support of Dr. Gralow
$8,500 granted in 2003 for continued support of Dr. Gralow
$6,500 granted in 2004 for continued support of Dr. Gralow
$15,000 granted in 2005 for continued support of Dr. Gralow
$5,800 granted in 2006 for continued support of Dr. Gralow
$3,300 granted in 2007 for continued support of Dr. Gralow

USC / Kenneth Norris Comprehensive Cancer Center
1999: Pilot study on the utility of preoperative chemotherapy for locally advanced breast cancer using the promising new agent Paclitaxel.
$31,100

UCLA/Jonsson Comprehensive Cancer Center
1999: Research on whether a change in the composition of fat in the diet, not just the quantity of fat intake, can slow or halt the growth of breast tumors.
$21,100

Mountain States Medical Research Institute
1998: Seed grant for the study of CD40 expression in breast cancer; involvement in cytotoxicity and immune enhancement that may lead to significantly improved cancer treatments.
$15,000

Fred Hutchinson Cancer Research Center
1998: Grant for the development of community-based high dose chemotherapy programs that can be administered in smaller cancer centers.
$17,000

UCLA/Jonsson Comprehensive Cancer Center
1998: Grant used for clinical trials utilizing new promising developmental therapies for recurring breast cancer to increase chance of long-term survival.
$30,000 (50% provided through UCLA matching funds)

USC / Kenneth Norris Comprehensive Cancer Center
1998: Grant used for the detection of metastatic auxiliary lymph nodes with Positron Emission Tomography to reduce frequency of axillary node dissection and possibility of lymphedema side effect.
$30,000 (50% provided through USC matching funds)

Fred Hutchinson Cancer Research Center
1998: Molecular determinants of acquired and intrinsic drug resistance in breast cancer to increase efficacy of adjuvant drug therapies.
$18,000

University Of Wisconsin Medical Center
1998: Studies of a newly discovered natural substance (B-Lapachone derivatives) that kills metastatic breast cancer cells without toxicity to surrounding healthy cells.
$10,000

Duke Comprehensive Cancer Center
1998: Immunotherapy of breast cancer using autologous Dendritic cells pulsed with tumor Antigen.
$20,000

Jingwen Liu, Ph.D., Mountain States Medical Research Institute
1997: Oncosatin M (OM) research, a cytokine produced by white blood cells in the immune system which inhibits growth of breast cancer cells by blocking action of certain factors driving the wild growth of cancer cells.
$10,000

University Of Pennsylvania Cancer Center
1997: Phase I trial with TALL-104 cells in-patients with metastatic breast cancer.
$10,000

UCLA/Jonsson Comprehensive Cancer Center
1997: Studies as to whether a moderate intensity exercise program can decrease estrogen levels in premenopausal women at high risk for breast cancer.
$10,000

The Wistar Institute
1997: Research to isolate human genes associated with the process of metastatic breast cancer as well as continued study into the function of the BRCA 1 gene.
$30,000

Fred Hutchinson Cancer Research Center
1997: Scrutinizing societal shifts involving diet, exercise and environmental changes that may account for increase in breast cancer incidence.
$25,000